Vaccine, plasma products, antitoxins
Originally founded as Kaketsuken in 1945 and renamed KM Biologics in 2018, the company develops vaccines, plasma products, and antitoxins, in partnership with Meiji Group.
No hay datos disponibles
No hay elementos FAQ disponibles.